{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The year's big drug-industry merger may turn out to be about using marketing muscle to fight fat. In April, when the French drug company Sanofi-Synth\u00e9labo vanquished all other players with a long-shot takeover bid for a much larger French-German rival, Aventis, many commentators focused on the role of politicians in Paris.", "headline": {"main": "Diet Pill Was a Driving Force in a French Drug Merger"}, "abstract": "French drug company Sanofi-Synthelabo's acquisition of French-German rival Aventis linked to Sanofi's new drug rimonabant, which will be marketed as Acomplia, that fights obesity and smoking; drug was in Sanofi's pipeline long before merger of company, now called Sanofi-Aventis; analysts and doctors say drug could become one of industry's once-in-a-decade blockbusters; Sanofi plans to file for regulatory approval early next year in US and Europe; hopes to put drug on market in 2006; Sanofi needed Aventis's powerful sales force to market drug; photo (M)", "print_page": "1", "word_count": 1761, "_id": "4fd280178eb7c8105d84a982", "snippet": "The year's big drug-industry merger may turn out to be about using marketing muscle to fight fat.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/09/07/business/07drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "EUROPE"}, {"name": "organizations", "value": "SANOFI-AVENTIS"}, {"name": "organizations", "value": "SANOFI-SYNTHELABO SA"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "GLAXOSMITHKLINE"}, {"name": "organizations", "value": "PFIZER INCORPORATED"}, {"name": "organizations", "value": "AVENTIS"}, {"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "OBESITY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "SMOKING AND TOBACCO"}, {"name": "subject", "value": "RIMONABANT (DRUG)"}, {"name": "subject", "value": "ACONMPLIA (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Mark", "rank": 1, "lastname": "LANDLER"}], "original": "By MARK LANDLER; Denise Grady contributed reporting for this article"}, "document_type": "article", "pub_date": "2004-09-07T00:00:00Z", "section_name": "Business"}, {"type_of_material": "Series", "blog": [], "news_desk": "National Desk", "lead_paragraph": "American workers are stressed out, and in an unforgiving economy, they are becoming more so every day. Sixty-two percent say their workload has increased over the last six months; 53 percent say work leaves them ''overtired and overwhelmed.''", "headline": {"main": "Always on the Job, Employees Pay With Health", "kicker": "Sick of Work"}, "abstract": "First article in series Sick of Work focuses on health damage caused by job-related stress; researchers are finding that growing stress and uncertainty of office have measurable impact on workers' health and, by extension, corporate profits; workplace stress reportedly costs nation over $300 billion a year in health care, missed work and stress-reduction spending; graphs compare sick time and illness when business is bad and good; photos (M)", "print_page": "1", "word_count": 2976, "_id": "4fd259a78eb7c8105d805c9d", "snippet": "Workplace stress has a measurable impact on Americans' health and costs the nation more than $300 billion each year.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/09/05/health/05stress.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "SURVEYS AND SERIES"}, {"name": "subject", "value": "STRESS (HUMAN)"}, {"name": "subject", "value": "WORKING HOURS"}, {"name": "subject", "value": "OBESITY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "INDUSTRIAL AND OCCUPATIONAL HAZARDS"}, {"name": "subject", "value": "FAMILIES AND FAMILY LIFE"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "John", "rank": 1, "lastname": "SCHWARTZ"}], "original": "By JOHN SCHWARTZ"}, "document_type": "article", "pub_date": "2004-09-05T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The major heart operation that former President Bill Clinton is to undergo early next week restores blood flow around blockages that prevent coronary arteries from nourishing the heart, allowing the vast majority of patients to lead normal lives. In past interviews, Mr. Clinton said he has long been concerned about developing heart disease because it runs in his mother's family. But even people like Mr. Clinton who exercise, adhere to healthy diets, take statin drugs and get regular medical checkups may eventually need surgery because the underlying disease -- atherosclerosis -- can be relentless.", "headline": {"main": "Clinton Operation Aims To Restore Blood Flow"}, "abstract": "Bill Clinton will undergo bypass surgery to restore blood flow around blockages that prevent coronary arteries from nourishing heart; bypass connections restore blood flow but do not cure underlying disease of atherosclerosis; doctors recommended surgery after Clinton underwent coronary angiogram; Clinton's medical history discussed; drawing (M)", "print_page": "15", "word_count": 1327, "_id": "4fd23e508eb7c8105d7d478b", "snippet": "The heart operation that former President Clinton is to undergo restores blood flow around blockages that prevent coronary arteries from nourishing the heart.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/09/04/national/04heart.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "UNITED STATES POLITICS AND GOVERNMENT"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN; Denise Grady contributed reporting for this article"}, "document_type": "article", "pub_date": "2004-09-04T00:00:00Z", "section_name": "Health; U.S.; Washington"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Note: This lesson was originally published on an older version of The Learning Network; the link to the related Times article will take you to a page on the old site.", "headline": {"main": "Speech! Speech!", "kicker": "The Learning Network"}, "abstract": "In this lesson, students consider how word choices in speeches impact their meaning and effectiveness by examining and responding to some of the speeches made at the 2004 Republican and Democratic National Conventions.", "print_page": null, "word_count": 2725, "_id": "4fd363c58eb7c8105d8b271c", "snippet": "In this lesson, students consider how word choices in speeches impact their meaning and effectiveness by examining and responding to some of the speeches made at the 2004 Republican and Democratic National Conventions.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2004/09/03/speech-speech/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michelle", "lastname": "SALE"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Javaid", "lastname": "KHAN"}], "original": "By MICHELLE SALE and JAVAID KHAN"}, "document_type": "blogpost", "pub_date": "2004-09-03T12:45:00Z", "section_name": "U.S."}], "meta": {"hits": 4, "offset": 0, "time": 36}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}